Multiple Assemblies exist for SMTL entry 1nd0
CATIONIC CYCLIZATION ANTIBODY 4C6 COMPLEX WITH TRANSITION STATE ANALOG; X-RAY DIFFRACTION 2.45 Å

	SMTL ID 1nd0.1 Ligands (1s,4s)-4-[dimethyl(phenyl)silyl]-1-methylpiperidine 1-oxide; SULFATE ION Polypeptides IMMUNOGLOBULIN IGG2A; IMMUNOGLOBULIN IGG2A Oligo-state hetero-2-2-mer
	SMTL ID 1nd0.2 Ligands (1s,4s)-4-[dimethyl(phenyl)silyl]-1-methylpiperidine 1-oxide; SULFATE ION Polypeptides IMMUNOGLOBULIN IGG2A; IMMUNOGLOBULIN IGG2A Oligo-state hetero-2-2-mer
	SMTL ID 1nd0.3 Ligands (1s,4s)-4-[dimethyl(phenyl)silyl]-1-methylpiperidine 1-oxide; SULFATE ION Polypeptides IMMUNOGLOBULIN IGG2A; IMMUNOGLOBULIN IGG2A Oligo-state hetero-1-1-mer
	SMTL ID 1nd0.4 Ligands (1s,4s)-4-[dimethyl(phenyl)silyl]-1-methylpiperidine 1-oxide; SULFATE ION Polypeptides IMMUNOGLOBULIN IGG2A; IMMUNOGLOBULIN IGG2A Oligo-state hetero-1-1-mer
	SMTL ID 1nd0.5 Ligands (1s,4s)-4-[dimethyl(phenyl)silyl]-1-methylpiperidine 1-oxide; SULFATE ION Polypeptides IMMUNOGLOBULIN IGG2A; IMMUNOGLOBULIN IGG2A Oligo-state hetero-1-1-mer
	SMTL ID 1nd0.6 Ligands (1s,4s)-4-[dimethyl(phenyl)silyl]-1-methylpiperidine 1-oxide; SULFATE ION Polypeptides IMMUNOGLOBULIN IGG2A; IMMUNOGLOBULIN IGG2A Oligo-state hetero-1-1-mer